FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1255590003: Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy (observable entity)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5147725011 Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy (observable entity) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5151055013 Presence of regression of primary malignant gastrointestinal stromal tumor after neoadjuvant antineoplastic therapy en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5156476013 Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5158104014 Presence of regression of primary malignant gastrointestinal stromal tumour after neoadjuvant antineoplastic therapy en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy (observable entity) Inheres in Gastrointestinal stromal sarcoma true Inferred relationship Some 4
Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy (observable entity) Property (attribute) Presence (property) (qualifier value) true Inferred relationship Some 1
Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy (observable entity) Scale type (attribute) Ordinal value true Inferred relationship Some 2
Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy (observable entity) Characterizes (attribute) Regression of neoplasm (qualifier value) true Inferred relationship Some 5
Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy (observable entity) Precondition (attribute) Neoadjuvant antineoplastic therapy (procedure) true Inferred relationship Some 6
Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy (observable entity) Time aspect (attribute) Single point in time true Inferred relationship Some 3
Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy (observable entity) Is a Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) true Inferred relationship Some
Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy (observable entity) Characterizes (attribute) Malignant proliferation of primary neoplasm (qualifier value) true Inferred relationship Some 7

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

GB English

US English

Back to Start